Clinical predictors for germline mutations in Head and neck paraganglioma patients: cost reduction strategy in Genetic diagnostic process as fail-out
dc.contributor.author | Neumann, Hartmut P. H. | |
dc.contributor.author | Erlic, Zoran | |
dc.contributor.author | Boedeker, Carsten Christof | |
dc.contributor.author | Rybicki, Lisa A. | |
dc.contributor.author | Robledo, Mercedes | |
dc.contributor.author | Sevilla García, María Agustina | |
dc.contributor.author | Hermsen, Mario | |
dc.date.accessioned | 2016-03-14T16:52:37Z | |
dc.date.available | 2016-03-14T16:52:37Z | |
dc.date.issued | 2009 | |
dc.identifier.citation | Cancer Research, 69(8), p. 3650-3656 (2009); doi:10.1158/0008-5472.CAN-08-4057 | |
dc.identifier.issn | 0008-5472 | |
dc.identifier.uri | http://hdl.handle.net/10651/35609 | |
dc.description.sponsorship | Grant 107995 (H.P.H. Neumann), the Deutsche Forschungsgemeinschaft (NE 571/5-3; H.P.H. Neumann), and the European Union (LSHC-CT-2005-518200; H.P.H. Neumann). C. Eng is the recipient of a Doris Duke Distinguished Clinical Scientist Award, and is the Sondra J. and Stephen R. Hardis Endowed Chair of Cancer Genomic Medicine at the Cleveland Clinic. C. Suarez is supported by a grant from the Fondo de Investigaciones Sanitarias (FIS; PI052071) and Red Tematica de Investigacio ́n Cooperativa en Ca ́ncer (RD06/0020/0034). M. Robledo is supported by a grant from FIS (PI042154) and Centro de Investigacio ́n Biome ́dica En Red de Enfermedades Raras. | |
dc.description.statementofresponsibility | Neumann, H.P.H., Erlic, Z., Boedeker, C.C., Rybicki, L.A., Robledo, M., Hermsen, M., Schiavi, F., Falcioni, M., Kwok, P., Bauters, C., Lampe, K., Fischer, M., Edelman, E., Benn, D.E., Robinson, B.G., Wiegand, S., Rasp, G., Stuck, B.A., Hoffmann, M.M., Sullivan, M., Sevilla, M.A., Weiss, M.M., Peczkowska, M., Kubaszek, A., Pigny, P., Ward, R.L., Learoyd, D., Croxson, M., Zabolotny, D., Yaremchuk, S., Dra, W., Muresan, M., Lorenz, R.R., Knipping, S., Strohm, M., Dyckhoff, G., Matthias, C., Reisch, N., Preuss, S.F., Eßer, D., Walter, M.A., Kaftan, H., Stöver, T., Fottner, C., Gorgulla, H., Malekpour, M., Zarandy, M.M., Schipper, J., Brase, C., Glien, A., Kühnemund, M., Koseielny, S., Schwerdtfeger, P., Välimäki, M., Szyfter, W., Finckh, U., Zerres, K., Cascon, A., Opocher, G., Ridder, G.J., Januszewicz, A., Suarez, C., Eng, C. | |
dc.format.extent | p. 3650-3656 | |
dc.language.iso | eng | |
dc.relation.ispartof | Cancer Research | |
dc.rights | © 2009 American Association for Cancer Research | |
dc.source | Scopus | |
dc.source.uri | http://www.scopus.com/inward/record.url?eid=2-s2.0-66049145825&partnerID=40&md5=3f0bf7cf31134965931bb888a4cc60c4 | |
dc.title | Clinical predictors for germline mutations in Head and neck paraganglioma patients: cost reduction strategy in Genetic diagnostic process as fail-out | |
dc.type | journal article | |
dc.identifier.doi | 10.1158/0008-5472.CAN-08-4057 | |
dc.relation.publisherversion | http://dx.doi.org/10.1158/0008-5472.CAN-08-4057 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Artículos [37543]